Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New isosorbide mononitrate derivatives with reduced tolerance under study at Lacer

May 16, 2000

Compounds and methods for treating atherosclerosis and other coronary artery diseases

May 16, 2000

Potent CETP inhibitors in the Pharmacia pipeline

May 16, 2000

United Therapeutics to begin Flolan-to-Uniprost transition study

May 15, 2000

TP-10 phase I/II study results presented at cardiovascular anesthesiology meeting

May 15, 2000

Chloride channel blockers as novel therapeutic approach to sickle cell disease and other disorders

May 15, 2000

Medinox and Fuso to collaborate on development of new NO-neutralizing drug

May 12, 2000

Actelion announces results from phase III trial in pulmonary hypertension

May 12, 2000

Endovasc obtains funding to advance preclinical testing of NRA

May 12, 2000

Angiotensin II inhibition reduces early atherogenesis in monkeys

May 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...